METTL1 and neoplasm: Our findings indicate that inhibiting METTL1 activity leads to favourable changes within the tumour, such as an increased presence of anti-tumoural cytokines and the infiltration of cytotoxic immune cells, including M1-like macrophages and CD8+ T cells.